Measuring and Increasing the Effectiveness of the Quality Improvement Implementation Change Practices of Front-Line Maternity Physician and Nurse Leaders

Total Page:16

File Type:pdf, Size:1020Kb

Measuring and Increasing the Effectiveness of the Quality Improvement Implementation Change Practices of Front-Line Maternity Physician and Nurse Leaders View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Carolina Digital Repository Measuring and Increasing the Effectiveness of the Quality Improvement Implementation Change Practices of Front-Line Maternity Physician and Nurse Leaders Debra Bingham, MS, RN A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctorate of Public Health in the Department of Health Policy and Management of the School of Public Health Chapel Hill 2009 Approved by: Peggy Leatt, PhD Cheryl B. Jones, PhD, RN Jeffery B. Gould, MD, MPH Carol Sakala, PhD, MSPH Rebecca Wells, PhD © 2009 Debra Bingham, MS, RN ALL RIGHTS RESERVED ii Abstract Debra Bingham, MS, RN Measuring and Increasing the Effectiveness of the Quality Improvement Implementation Change Practices of Front-Line Maternity Physician and Nurse Leaders (Under the direction of Peggy Leatt, PhD, Cheryl B. Jones, PhD, RN, Jeffery B. Gould, MD, MPH, Carol Sakala, PhD, MSPH and Rebecca Wells, PhD) Measuring and increasing the effectiveness of the QI implementation change practices of front-line leaders offers the promise of saving lives and reducing harm and suffering to patients. Leaders have limited information on how to measure and increase the effectiveness of their QI implementation practices. Design: Qualitative, non-experimental, retrospective, cross-case study. Sample: Purposive sample of 7 front-line physician and nurse leaders and 12 QI projects, controlled for multiple context variables. Conclusions: The conceptual framework, Leaders’ Expectations of Change Compliance , emerged based on the analysis of the reasons leaders did not set target dates. The QI implementation tactics used by the leaders were determined to be components of three types of strategies : education, data and discourse. QI project patterns were identified; there was no single combination of strategies, tactics, and barriers that led to greater QI progress. The five critical determinants of the QI patterns were: 1) Amount of leader persuasion, 2) Whether a leader had fully conceptualized the QI project, 3) Amount of clinician persuasion, 4) iii Presence or absence of meaningful data, and 5) How leaders responded to resisters. The patterns are similar for QI projects with the same QI topics and goals. Counting the number of QI implementation tactics the leaders used is not an accurate measure of QI implementation progress. Four types of implementation barriers : Leader, clinician, characteristics of the QI Projects, climate, and resource barriers. There was no distinguishable relationship between the number of tactics used and the number of barriers identified. Implementation Plan Objective: Increase leaders’ abilities to conceptualize their QI implementation strategy and how they choose their QI implementation tactics based on the barriers they anticipate and encounter. Research Recommendations: Conduct further research on QI regarding: concepts, project timing, health information technology (HIT), setting target dates, discourse and change, creative types of implementation tactics, and multi-hospital and multi-stakeholder collaboratives. Health Policy Recommendations: Develop hospital-based Rapid Response QI Teams that can be activated during a quality and safety emergency, train new and current clinicians to conceptualize, implement and reach QI goals, increase QI implementation research funding, develop a QI topic-specific implementation registry, and integrate QI and HIT. iv Dedication To My Husband: Kent Hamilton To My Parents: VerNon and Bernice Bingham To My Children and Their Spouses: Tara and Shawn Steenson David Jones and Sarah Sacuto Lauren and Jeff Wind Tiffany and Fred Schoppe To My Grandchildren: Shawn Curtis, Mariah, Joshua, Caleb, and Katie Steenson Oslo Wind Olivia Jones To My Sisters: Brenda Anderson and Linda Coy v Acknowledgements There are many people who supported me through my doctoral studies and dissertation. With their support and encouragement the journey has been more rewarding; the end product of higher quality. My husband, Kent Hamilton deserves the most thanks and acknowledgement. Kent’s continuous love and support is invaluable. Kent spent countless hours participating in discussions about my work and reading, editing, and re-reading multiple drafts. His optimism about my abilities, coupled with his willingness to jump in and help, provided me with a kind and productive environment to work within. My long-time friends, Zola Golub and Reesa Vaughter inspire me to strive for excellence not only throughout the dissertation process, but through all aspects of my life. I am particularly grateful to Reesa for regularly spending many hours reading very rough drafts of my work, providing me with insightful comments and questions, and helping me see the flaws in my work in such a way that I was not discouraged to keep pressing forward. Reesa’s ability to give timely, broad and detailed guidance was invaluable. Zola is my mentor and friend. Words do not adequately describe the gratitude I feel toward Zola for the positive influence she has on the course of my life. As with many other endeavors I have chosen to pursue, Zola provided me keen insight and support every step of the way. Because of Zola, I am more confident and my life is richer and fuller. vi I have the good fortune to be the daughter of VerNon and Bernice Bingham. My parents are life-long learners, big dreamers, and hard workers. They have accomplished goals that others told them were impossible. For example, during the years that my father was the High School Spanish teacher in Brigham City, Utah, they organized inexpensive trips to Mexico that thousands of youth participated in. Their trips grew into a phenomenon that changed the cultural landscape of several communities. My parents were raised with minimal means on small farms in small towns. But their humble roots did not constrain or define them. They have lived and worked in many countries in the world and continue in their 80’s to seek educational and cultural experiences by continuing to travel the world. Their example and their love sustain me and motivate me in countless ways. My children, their spouses, and my grandchildren bring me great joy. I look at them and marvel at the miracle of life. In fact, one of the major reasons I have been striving to learn more and accomplish more is to, in my sphere of influence, improve health care for them and my other loved ones. Thus, it was timely and fitting that during the writing of my dissertation two new grandchildren were born; Oslo Wind and Olivia Jones. It is also personally rewarding that my son, David Jones has also chosen to pursue a career in Public Health. Although my studies at the University of North Carolina were begun prior to his starting his Masters of Science in Public Health, I pushed myself harder so that we could graduate on the same day, from the same Department, from the same University. I acknowledge both of my sisters, Brenda and Linda. Brenda died an untimely death during my coursework. However, despite the loss of being able to call her on the phone and visit her in person, I have felt encouraged throughout my studies by how Brenda lived her life. When I was the most exhausted, I would think of Brenda. Remembering how Brenda vii lived, even when her body was dying a painful death, encouraged me to keep challenges in perspective. Linda and I are close in age. Thus, Linda has been both my sister and a trusted friend throughout my life. I could always count on her to be there for me. I have always admired Linda and turn regularly to her for advice and support; my doctoral studies were no different. Thus, I want to acknowledge her on-going support for my entire life, of which only a few years included my doctoral studies. Throughout my life, Brenda’s and Linda’s consistent faith in my abilities gave me greater courage not to shy away from challenges that were new and often daunting. My brothers, brothers-in-law, and sister-in-law are also very dear to me. I acknowledge them for their support and encouragement. I also thank John Gruntkowski, Bonnie Seelos and my nieces and nephews, of which I am blessed to have many. I thrill at their accomplishments and I value their interest in my work. Since I am the first person in my immediate and extended family to get a doctorate degree, I hope that my accomplishments will make the educational and professional goals for all members of my family seem less formidable and more approachable than they have often appeared to me. Many friends and colleagues in New York City encouraged me to pursue my doctorate degree. I acknowledge them for the positive influence they have on my work and their on-going encouragement throughout the process. There are too many of them to name each one individually. Moving to California during the second semester of my coursework, added the necessary stress and opportunity of finding new employment and developing new professional colleagues. I am grateful to everyone in California who welcomed me and supported my educational goals; there are too many for me to be able to name each one viii individually. However, I particularly want to thank Barbara Murphy and Elliott Main for providing me an employment environment that has been both stimulating and flexible; they understood and valued the fact that my studies informed my work. Without Barbara’s and Elliott’s interest in and support of my doctoral studies, the difficult task of juggling multiple priorities would have been even that much more difficult. For the past three years, Elliott and I have traveled together all over California and to the East coast in order to form the precedent-setting California Maternal Quality Care Collaborative (CMQCC).
Recommended publications
  • The Conclusion Report of 13Th National Perinatology Congress
    Perinatal Journal 2011;19(1):35-50 e-Adress: http://www.perinataljournal.com/20110191009 doi:10.2399/prn.11.0191009 The Conclusion Report of 13th National Perinatology Congress Ayfle Kafkasl›1, Alper Tanr›verdi2, Yeflim Baytur3, Özlem Pata3, Ertan Adal›3, Hakan Camuzcuo¤lu3, Arif Güngören3, ‹lker Ar›kan3 1Head of the Congress, 13th National Perinatology Congress, ‹stanbul Türkiye 2Congress Secretary, 13th National Perinatology Congress, ‹stanbul Türkiye 3Congress Reporter, 13th National Perinatology Congress, ‹stanbul Türkiye The Conclusion Report of 13th The subject of “Fetal Postmortem Examination National Perinatology Congress and Chromosomal Analysis of Abortion Material” 13th National Perinatology Congress was held was presented by Dr. Gülay Ceylaner. According in ‹stanbul Military Museum and Culture Site in to the results of this presentation, postmortem between 13th and 16th April, 2011. examination should be performed on congenital anomalies, intrauterine growth retardation, non- Before the congress, 3 pre-congress courses immune hydrops fetalis, fetal-neonatal death histo- were held on 13th April, 2011. ry of unknown etiology or in fetuses with unknown death reason or maser (high frequency 1. Perinatal Genetic and Postmortem of chromosomal disorder). Findings should cer- Diagnosis Course tainly be recorded during examination, pho- In the first session, Assoc. Prof. Serdar Ceylaner tographs and X-ray should be taken and skin biop- made a presentation about “Basic Genetics and sy should be done. Fetus evaluation is really an Management of Genetic Diseases for the Clinician” easy and convenient examination method. and he explained that chromosomal analysis indi- In the presentation of “Fetal Autopsy: The cations are recurrent gestational losses, intrauterine Influence on Perinatal Mortality”, Prof.
    [Show full text]
  • Lung Growth and Lung Function Alter A) Fetal Lamb Tracheal Occlusion
    • Lung Growth and Lung Function Alter a) Fetal Lamb Tracheal Occlusion and Exogenous Surfactant at Birth in Congenital Diaphragmatic Hernia and b) Selective Perfluorocarbon Distention in Healthy Newborn Piglets Andreana Bütter Department ofExperimental Surgery McGill University, Montreal • Submitted June, 2001 A thesis submitted to the Faculty of Graduate Studies and Research in partial fulfillment ofthe requirements ofthe degree ofMaster ofScience © Andreana Bütter, 2001 • Nationallibrary BibbolhèQue nationale 1+1 of·Canada duClnadi Acquisitions et services bibliographiques _.rueW~ 0ftaM ON K1A ClN4 0INdlI The author bas anmted a DOD­ L'auteur a acconIé une licence DOn Bdusiwlicence aBowÎDI the exclusive pametbmt à la Natioual LiI:ny ofCuada to Biblioth6que DltiODlle du CaDada de œproduco, 1oaD, distribute or sen reproduire, Jdter. distribua- ou copi. oItbis tbesis ÎD microfonn, vendre des caP- de celte daàe sous pep«or electrorûc formats. la forme de mic:rofidleIfiJ de reproduction sur papier ou sur format Sectronique. The author ret- 0WMrSbip ofthe L'auteur CODIeI'W la propri6t6 .. copyriabt in tbis thesïs. Neitber the droit d'auteur qui P'Otèae cette". thesis .......tiaI exIrads hmil Ni la th6se Di des eJdJills substantiels may be priDted or otbawise de ceJle.ci De doiwDt an impIimés reproduced without the 8UthÔr's ou autremeoI repJoduits saas son permission. autorisation. 0-612-B0111-X Canadl TABLE OF CONTENTS Page Abstract 3 Abrégé 4 • Acknowledgements 5 Dedication 6 Abbreviations 7 Introduction 9 Review ofthe Literature: A. Normal Lung Development 11 B. Normal Diaphragm Development 12 C. Pathophysiology ofCDH 12 D. Animal Models ofCDH 14 E. Prenatal Interventions to Treat CDH 1. Tracheal Occlusion 14 2.
    [Show full text]
  • GLOBAL CENSORSHIP Shifting Modes, Persisting Paradigms
    ACCESS TO KNOWLEDGE RESEARCH GLOBAL CENSORSHIP Shifting Modes, Persisting Paradigms edited by Pranesh Prakash Nagla Rizk Carlos Affonso Souza GLOBAL CENSORSHIP Shifting Modes, Persisting Paradigms edited by Pranesh Pra ash Nag!a Ri" Car!os Affonso So$"a ACCESS %O KNO'LE(GE RESEARCH SERIES COPYRIGHT PAGE © 2015 Information Society Project, Yale Law School; Access to Knowle !e for "e#elo$ment %entre, American Uni#ersity, %airo; an Instituto de Technolo!ia & Socie a e do Rio+ (his wor, is $'-lishe s'-ject to a %reati#e %ommons Attri-'tion./on%ommercial 0%%.1Y./%2 3+0 In. ternational P'-lic Licence+ %o$yri!ht in each cha$ter of this -oo, -elon!s to its res$ecti#e a'thor0s2+ Yo' are enco'ra!e to re$ro 'ce, share, an a a$t this wor,, in whole or in part, incl' in! in the form of creat . in! translations, as lon! as yo' attri-'te the wor, an the a$$ro$riate a'thor0s2, or, if for the whole -oo,, the e itors+ Te4t of the licence is a#aila-le at <https677creati#ecommons+or!7licenses7-y.nc73+07le!alco e8+ 9or $ermission to $'-lish commercial #ersions of s'ch cha$ter on a stan .alone -asis, $lease contact the a'thor, or the Information Society Project at Yale Law School for assistance in contactin! the a'thor+ 9ront co#er ima!e6 :"oc'ments sei;e from the U+S+ <m-assy in (ehran=, a $'-lic omain wor, create by em$loyees of the Central Intelli!ence A!ency / em-assy of the &nite States of America in Tehran, de$ict.
    [Show full text]
  • Prenatal Corticosteroids for Reducing Morbidity and Mortality After Preterm Birth
    PRENATAL CORTICOSTEROIDS FOR REDUCING MORBIDITY AND MORTALITY AFTER PRETERM BIRTH The transcript of a Witness Seminar held by the Wellcome Trust Centre for the History of Medicine at UCL, London, on 15 June 2004 Edited by L A Reynolds and E M Tansey Volume 25 2005 ©The Trustee of the Wellcome Trust, London, 2005 First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2005 The Wellcome Trust Centre for the History of Medicine at UCL is funded by the Wellcome Trust, which is a registered charity, no. 210183. ISBN 978 0 85484 102 8 Histmed logo images courtesy of the Wellcome Library, London. All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/ Please cite as: Reynolds L A, Tansey E M. (eds) (2005) Prenatal Corticosteroids for Reducing Morbidity and Mortality after Preterm Birth. Wellcome Witnesses to Twentieth Century Medicine, vol. 25. London: Wellcome Trust Centre for the History of Medicine at UCL. CONTENTS Illustrations and credits v Witness Seminars: Meetings and publications; Acknowledgements vii E M Tansey and L A Reynolds Introduction xxi Barbara Stocking Transcript 1 Edited by L A Reynolds and E M Tansey Appendix 1 85 Letter from Professor Sir Graham (Mont) Liggins to Sir Iain Chalmers (6 April 2004) Appendix 2 89 Prenatal glucocorticoids in preterm birth: a paediatric view of the history of the original studies by Ross Howie (2 June 2004) Appendix 3 97 Premature sheep and dark horses: Wellcome Trust support for Mont Liggins’ work, 1968–76 by Tilli Tansey (25 October 2005) Appendix 4 101 Prenatal corticosteroid therapy: early Auckland publications, 1972–94 by Ross Howie (January 2005) Appendix 5 103 Protocol for the use of corticosteroids in the prevention of respiratory distress syndrome in premature infants.
    [Show full text]
  • Antenatal Steroids for Women at Risk of Preterm Delivery
    Revised: November 2020 ANTENATAL STEROIDS FOR WOMEN AT RISK OF PRETERM DELIVERY CHOICE OF AGENT: Two regimens of antenatal glucocorticoid treatment have evolved and are effective for accelerating fetal lung maturity 1. Betamethasone (two doses of 12 mg given intramuscularly 24 hours apart) preferred agent if available. 2. Dexamethasone (four doses of 6 mg given intramuscularly 12 hours apart). GESTATIONAL AGE AT ADMINISTRATION: 1. Administration of steroids for patients with threatened and imminent periviable birth at less than 220/7 weeks is not recommended. 2. Administration of steroids for patients with threatened and imminent periviable birth between 220/7 and 236/7 weeks can be considered after counseling by both MFM and NICU based on existing evidence.1-4 3. All fetuses between 240/7 and 336/7 weeks of gestation at risk of preterm delivery should be considered candidates for antenatal treatment with corticosteroids regardless of membrane status (intact or ruptured). 4. In women with a singleton pregnancy between 340/7 and 366/7 weeks who are at high risk for preterm birth within next 7 days (and before 370/7 weeks of gestation), we recommend treatment with a course of betamethasone (without tocolysis) provided they meet eligibility criteria. a. Inclusion criteria: i. Singleton pregnancy ii. Gestational age at presentation between 340/7 and 366/7 weeks iii. High probability of delivery (any one of the following): 1. Preterm labor with intact membranes and at least 3cm dilation or 75% effacement 2. Delivery expected by induction of labor or cesarean section in no less than 24 hours and no more than 7 days, as deemed necessary by the provider.
    [Show full text]
  • Disciplining Criminal Justice: the Peril Amid the Promise of Numbers
    YALE LAW & POLICY REVIEW Disciplining Criminal Justice: The Peril amid the Promise of Numbers Mary De Ming Fan* Introduction ........................................................................................................... 2 Governing Governance and the Manufacture of "Objective" Visibility ............ 1O A. The Law of Making Performance Visible ................................................ 14 B. Difficulties Defining Criminal Justice in the Idiom of Targets .............. 16 C. Bending the Bounds of the Officially Sanctioned .................................. 24 II. Expressive, Expiatory "Deliverables". ............................................................. 27 A. At the Point of Policy Failure ................................................................... 30 B. Numbers that Do Not Attain Aims ......................................................... 36 C. What Expiation by Numerical Proxy Effaces ......................................... 42 1. Aim ing Beyond the Baseline ............................................................ 42 2. Effacing H igher Aim s ........................................................................ 49 III. Toward a Policy Embrace of Values and Numbers in Qualitative Context ... 57 A. Q ualitative Perspective ............................................................................ 57 B. How Law and Policy Can Be Conducive to Qualitative Evaluation ........... 59 C on clusion ...................................................................................................................
    [Show full text]
  • RMHP Perinatal Care Guideline
    Perinatal Care Guideline Gestational Assessments Routine Lab/Diagnostic Routine Patient Education High Risk Lab/ High Risk Counseling Age Procedures Diagnostic Procedure Up to 12 Weeks Screen for Preterm labor (PTL) risk Complete Blood Count or Premature labor signs and symptoms Chorionic villi sampling Domestic Violence factorsat first visit HCT/HGB Appropriate weight gain based on BMI (CVS)if indicated Remain alert for signs Screen for sexually transmitted disease Urinalysis with culture and E x e r c i s e Ultrasound (US) Chronic Hypertension Calculate BMI and set weight gain goals follow up with test for cure if N u t r i t i o n Offer Cystic fibrosis screen Early and frequent visits for pregnancy positive Smoking Cessation - referral to CO Quit Offer nuchal translucency Advise about the adverse effects of smoking and alcohol and drug Assess fundal height measurements, Blood Group & Rh Type Toxoplasmosis measurements and abuse FHT’s, weight, and blood pressure biochemical markers to Antibody screen Communicable diseases Nutritional counseling regarding diet and salt intake Assess for gestational diabetes mellitus detect Down syndrome and Syphilis screen Sexual activity Obesity (GDM) risk factors and screen if high other genetic disorders Cervical Cytology Breastfeeding Importance of optimal weight gain and exercise risk Other genetic testing Hepatitis B Seat belt use during pregnancy Dietician consult as needed Assess oral health and refer for dental Rubella Antibodies Dental hygiene, flossing and
    [Show full text]
  • NICU Data Manual of Definitions
    NICU Data Manual of Definitions 2020 2 Table of Contents Table of Contents ............................................................................................................... 2 Introduction ....................................................................................................................... 12 NICU Data Eligibility ......................................................................................................... 13 NICU Data DRD Form and Admission/Discharge Form ................................................. 17 Demographics ............................................................................................................... 17 Hospital ID [HOSPNO] .............................................................................................. 17 Infant ID [ID] .............................................................................................................. 17 Year of Birth [BYEAR] ............................................................................................... 17 Deleted Flag .............................................................................................................. 17 Item 1. Birth Weight [BWGT] .................................................................................... 17 Item 2. Head Circumference at Birth [BHEADCIR] .................................................. 18 Item 3. Best Estimate of Gestational Age [GAWEEKS], [GADAYS] ....................... 18 Infant's Date and Time of Birth ................................................................................
    [Show full text]
  • Please Don't Aim for a Highly Cited Paper
    AUSTRALIAN UNIVERSITIES’ REVIEW Please don’t aim for a highly cited paper Michael C Calver Murdoch University Citation-based metrics are important in determining careers, so it is unsurprising that recent publications advise prospective authors on how to write highly cited papers. While such publications offer excellent advice on structuring and presenting manuscripts, there are significant downsides, including: restrictions in the topics researched, incentives to misconduct and possible detriments to motivation, innovation and collegiality. Guides to writing highly cited papers also assume that all citations are equal, ignoring new directions in bibliometric research identifying ‘quality’ and perfunctory citations. Rather than pursuing citations, with the uncertainty about their significance and the potential negative consequences, authors may fare better by following evidence from several disciplines indicating that persistence, a focused research program, good methodology and publishing in relevant journals are more important in career development and disciplinary influence than the odd star paper. Research administrators could encourage such steps by considering innovative new multivariate assessments of research productivity, including assessing social impact. Keywords: citation, quality citation, motivation, misconduct, innovation, highly cited Introduction and clarity of style, encouraging people to aim consciously to write highly cited papers is concerning Increasingly, researchers find their track records under for five main reasons: (i) it narrows the scope of research scrutiny as supervisors and funding agencies seek the undertaken or published; (ii) the focus on reward most successful groups to fund, or individuals to reward may reduce intrinsic motivation, innovation and true with appointments, promotion, tenure or prizes (Corsi, collaboration but encourage mistakes and misconduct; D’Ippoliti & Lucidi, 2010; Oswald, 2010; Teixeira et al., (iii) despite substantial research, the significance of 2013).
    [Show full text]
  • The Future of Patient Flow Management Practices in the New Era of Health Reform
    The Future of Patient Flow Management Practices in the New Era of Health Reform David J Yu, MD, MBA, FACP, SFHM Medical Director, Adult Inpatient Medicine Service Presbyterian Medical Group ACA: Affordable Care Act ACO: Accountable Care Organizations • “It is anticipated that ACOs will increasingly be reimbursed under a capitated model that incentivizes optimal quality, safety, efficiency, and health outcomes for populations of patients.” – J. Haugham, MD, D. Burton, MD, HealthCatalyst Value over Volume: Quality over Quantity • Revenue at Risk • Patient Experience • Complication Consequences • Population Health Medicare Advantage Enrollment Bundle Payments • Payment for Episodes of Care – Hospital cost – Professional fee: all physician charges – Ancillary Service – SNF, Rehab • Middle ground between FFS and Capitation • Based on delivering episode of care at a lower price Payment Transparency • Commercial Insurance % of Medicare • ? Demise of Hospital Chargemaster Revenue Center versus Cost Center Patient Flow Traditional View • ED Physician Process owner • Discharge before noon • Observation units • Push patients up to medicine / surgical floor • Hall beds in ED/ Floor Patient Flow: Age of ACA • “A comprehensive, strategic initiative that hospitals need to align all their clinical departments, departmental budgets, and administrative processes around to achieve.” – Today’s Hospitalist, October 2014, David Yu, MD Patient Flow as a Strategic Initiative • How do you model financial efficiency in a cost center model? • No revenue generation
    [Show full text]
  • WHO Recommendations on Interventions to Improve Preterm Birth Outcomes
    WHO recommendations on interventions to improve preterm birth outcomes For more information, please contact: Department of Reproductive Health and Research World Health Organization ISBN 978 92 4 150898 8 Avenue Appia 20, CH-1211 Geneva 27, Switzerland Fax: +41 22 791 4171 E-mail: [email protected] www.who.int/reproductivehealth WHO recommendations on interventions to improve preterm birth outcomes WHO Library Cataloguing-in-Publication Data WHO recommendations on interventions to improve preterm birth outcomes. Contents: Appendix: WHO recommendations on interventions to improve preterm birth outcomes: evidence base 1.Premature Birth – prevention and control. 2.Infant, Premature. 3.Infant Mortality – prevention and control. 4.Prenatal Care. 5.Infant Care. 6.Guideline. I.World Health Organization. ISBN 978 92 4 150898 8 (NLM Classifi cation: WQ 330)Contents © World Health Organization 2015 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
    [Show full text]
  • Corticosteroids Antenatal Use Of
    King Edward Memorial Hospital Obstetrics & Gynaecology CLINICAL PRACTICE GUIDELINE Corticosteroids: antenatal use of This document should be read in conjunction with the Disclaimer Contents Dosage and administration of course of antenatal corticosteroids .. 2 Key points ............................................................................................................... 2 Background information .......................................................................................... 3 Administering corticosteroids to women with Diabetes .................... 4 Glycaemic management when receiving corticosteroids .................. 5 Management of women who have NOT had an Oral Glucose Tolerance Test (OGTT) in pregnancy .............................................................................................. 5 Normal glucose tolerance test ................................................................................. 6 Diet controlled gestational diabetes ........................................................................ 6 Gestational diabetes requiring insulin ..................................................................... 6 Type 1 or type 2 diabetes ....................................................................................... 7 References ............................................................................................ 8 Page 1 of 9 Corticosteroids: Antenatal use of Aim To provide clinical staff with the information necessary to ensure the safe management of women who are receiving corticosteroids
    [Show full text]